With prices low and inventory high, the sector lacks the dividend pricing power we look for. Read More
Archive
Filter
A stronger U.S. dollar weighs down earnings. Read More
National Grid is moving to higher-growth businesses. Read More
This spirits maker continues growing both its earnings and dividends. Read More
The Trans Pacific Partnership will help with patents and expansion into new countries. Read More
While no company is recession-proof, infrastructure-heavy ones tend to fare better in tough times. Read More
European companies are still showing a clear preference for boosting payouts. Read More
Nuveen’s top asset manager, Robert C. Doll, predicts more volatility and lower returns as he says the “easy money” has been made. Read More
We are adding Merck & Co. (NYSE: MRK) to the Global Income Edge Conservative Portfolio. In a continuation of our focus on solid health care stocks that we will provide solid dividend income, we found Merck & Co. to be undervalued now after the latest market declines and a management… Read More
Santander has great expectations, while Philip Morris is forced to sell part of its business. Read More